Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.
about
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!Renin-Angiotensin-aldosterone system in diabetes and hypertensionPrimary Aldosteronism: Changing Definitions and New Concepts of Physiology and Pathophysiology Both Inside and Outside the Kidney.Aldosterone production and insulin resistance in healthy adultsThe role of aldosteronism in causing obesity-related cardiovascular risk.Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewIncreased aldosterone among HIV-infected women with visceral fat accumulationCorrelation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart studyCirculating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidneyGreater exercise sweating in obese women with polycystic ovary syndrome compared with obese controlsMineralocorticoid receptors modulate vascular endothelial function in human obesityPara- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjectsVisceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterationsAbdominal obesity is characterized by higher pulse pressure: possible role of free triiodothyronine.Abnormal aldosterone physiology and cardiometabolic risk factors.Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system.Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adultsAdiposity has unique influence on the renin-aldosterone axis and blood pressure in black children.Management of patients with resistant hypertension: current treatment options.Resistant hypertension-complex mix of secondary causes and comorbiditiesThe renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress.Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects.The role of aldosterone in the metabolic syndrome.A comprehensive review of the clinical aspects of primary aldosteronism.A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.Aldosterone and renin in cardiac patients referred for catheterization.Aldosterone Production and Signaling Dysregulation in Obesity.Distinctive Risk Factors and Phenotype of Younger Patients With Resistant Hypertension: Age Is Relevant.Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension.The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.Increased total Renin levels but not Angiotensin-converting enzyme activity in obese patients with polycystic ovary syndrome.The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.
P2860
Q26776149-F846B089-96F7-48C6-BEE8-44DC3355271AQ28308222-E7BF4E28-B102-4C78-BE40-825ED0A60607Q30248429-5F5F9602-4E69-4145-8EC1-C7F65848ED2FQ33786853-656C614C-4E91-4F3C-A725-3D0351BF74D9Q33995992-A942F2F3-EB98-4FC6-AC08-60CA3C0CED77Q34018585-6508D2F9-68B5-4A42-A476-72AAA6145AD1Q34066641-ED00F0C9-A117-4AE9-A24C-E5E80F02CAB1Q34220048-9CA8F497-FAB9-4175-930B-CD9C9E33C41BQ34714245-242734FE-4305-4F12-9B79-FF71F613F009Q35026645-74349FBC-0711-4B25-8B25-10C98CA27392Q35028637-2A3C6063-06CE-47D1-AD9C-25D3E79E8E09Q35031976-3139C4C6-9756-46BE-ABEB-D1F230853C2EQ35792253-FBD5658F-2FA7-476E-8387-044078D15519Q36297722-97B32008-93B4-4933-AC79-57267A2FB6F5Q36308226-9B8DB171-8B01-44F1-9EA3-C41044B4C155Q36737227-B8C0ED01-9770-4CE4-97F4-6A1289DFFDFAQ37039244-2757FF96-AC2E-4B15-8F27-4AC2EB782A70Q37154403-ED828BE1-9FBB-4598-8F3C-12E2731F14ACQ37266193-6FBF0A5C-6777-4A99-A812-E44CD715AAF0Q37304418-D500D54B-E2F4-4853-93EB-028437D0B4F5Q37333220-68730917-98F2-4F7B-82F5-7D26EEA4D0F3Q37475546-CB1D0022-07A1-4E0C-8B80-0DDBFBC6AEC6Q37624307-239AFE5C-2987-49F5-B7BB-1D94DF119033Q37833554-3EF27217-6972-49F2-9965-346DAD1CEA33Q37879448-C9F240D3-8CA2-473B-A4D8-D0C1521CC224Q38108677-0DA50A21-269C-4641-80E8-58EBD0305704Q38151149-AE6207BF-8EEE-43DB-BA89-C6BA91058233Q38262065-98246A08-7EF6-4BAC-BE39-AB44350359CEQ38267493-5BF0152F-955D-4177-9912-BE662B34636EQ38675419-BB41A6C7-0F28-47CA-ABAE-1F4911006AD7Q38714084-AF284611-18D5-4C47-B10F-9DE00B7A200DQ38720544-AE45F84A-9ED0-4635-ADE8-E3701256B7BDQ38872907-03ED63A2-082E-4A77-A89E-B397A72254A4Q38960042-91E5AAB7-1829-43EB-BF27-AE1C9EA8BDD8Q39238938-CFAB8B52-0C27-4157-835F-41F12FA36E91Q39322673-0C1EC916-CEFB-4EAE-B881-DAD671C6B228Q40620899-1761074E-AA89-436F-9699-F8547FD9F6BAQ42759679-E1619410-F832-45FE-B98E-414D34F9096AQ43007154-535AFC55-0D98-4E8F-9B50-4CB82BEE1C6BQ43193916-40A8A6D1-600A-49C1-9CD2-18EB95ED85EE
P2860
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Body mass index predicts plasm ...... primary hypertensive patients.
@en
Body mass index predicts plasm ...... primary hypertensive patients.
@nl
type
label
Body mass index predicts plasm ...... primary hypertensive patients.
@en
Body mass index predicts plasm ...... primary hypertensive patients.
@nl
prefLabel
Body mass index predicts plasm ...... primary hypertensive patients.
@en
Body mass index predicts plasm ...... primary hypertensive patients.
@nl
P2093
P50
P356
P1476
Body mass index predicts plasm ...... primary hypertensive patients.
@en
P2093
Achille C Pessina
Anna Belfiore
Anna Patalano
Damiano Rizzoni
Ermanno Rossi
Franco Mantero
Gaetana Palumbo
Giampaolo Bernini
Gian Paolo Rossi
Graziella Caridi
P304
P356
10.1210/JC.2008-0251
P407
P577
2008-04-29T00:00:00Z